The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neuropsychopharmacology

• Publication date

  1995-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0893-133X(95)00140-9PMID 8747752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase

  2005cited by this paper
• The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801

  2004cited by this paper
• Opioid analgesics and antagonists

  1996cited by this paper
• Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase.

  1995cited by this paper
• Perspectives on the N-Methyl-D-Aspartate/Nitric Oxide Cascade and Opioid Tolerance

  1995cited by this paper
• Effects of Noncompetitive N-Methyl-D-Aspartate Receptor Antagonists on Opiate Tolerance and Physical Dependence

  1995cited by this paper
• Nitric Oxide Synthase Inhibitors

  1995cited by this paper
• Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine.

  1995cited by this paper
• Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat.

  1995cited by this paper
• Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist.

  1995cited by this paper
• N-Methyl-D-Aspartate (NMDA) Receptors, Mu and Kappa Opioid Tolerance, and Perspectives on New Analgesic Drug Development

  1995cited by this paper
• The Severity of Naloxone-Precipitated Opiate Withdrawal Is Attenuated by Felbamate, a Possible Glycine Antagonist

  1995cited by this paper
• The Role of the Locus Coeruleus and N-Methyl-D-Aspartic Acid (NMDA) and AMPA Receptors in Opiate Withdrawal

  1995cited by this paper
• Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal

  1995cited by this paper
• NMDA Antagonists as Neurotherapeutic Drugs, Psychotogens, Neurotoxins, and Research Tools for Studying Schizophrenia

  1995cited by this paper
• Dextromethorphan attenuates and reverses analgesic tolerance to morphine

  1994cited by this paper
• PATHOLOGICAL EFFECTS OF MK-801 IN THE RAT POSTERIOR CINGULATE/RETROSPLENIAL CORTEX

  1994cited by this paper
• Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists.

  1994cited by this paper
• Comparative effects of NG-monomethyl-d-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice

  1994cited by this paper
• Assessing structural changes in the brain to evaluate neurotoxicological effects of NMDA receptor antagonists.

  1994cited by this paper
• Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior.

  1994cited by this paper
• Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.

  1994cited by this paper
• 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance.

  1994cited by this paper
• Psychotherapeutic Medications Development Program (PMDP) Workshop on NMDA Receptor Antagonists: neurotoxicity evaluation. Introduction.

  1994cited by this paper
• Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.

  1994cited by this paper
• Cloned glutamate receptors.

  1994cited by this paper
• Nitric oxide and opioid tolerance.

  1994cited by this paper
• Pathological effects of MK-801 in the rat posterior cingulate/retrosplenial cortex.

  1994cited by this paper
• NEUROTOXICITY OF NMDA RECEPTOR ANTAGONISTS : AN OVERVIEW

  1994cited by this paper
• Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C

  1994cited by this paper
• Neurotoxicity of NMDA receptor antagonists: an overview.

  1994cited by this paper
• The NMDA Receptor antagonists, LY274614 and MK‐801, and the nitric oxide synthase inhibitor, NG‐nitro‐L‐arginine, attenuate analgesic tolerance to the mu‐opioid morphine but not to kappa opioids

  1994cited by this paper
• Effects of naltrexone pellet implantation on morphine tolerance and physical dependence in the rat.

  1994cited by this paper
• Effect of morphine tolerance and abstinence on the binding of [3H]MK-801 to brain regions and spinal cord of the rat.

  1994cited by this paper
• Assessing structural changes in the brain to evaluate neurotoxicological effects of NMDA receptor antagonists.

  1994cited by this paper
• Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.

  1993cited by this paper
• Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.

  1993cited by this paper
• Evidence for the role of nitric oxide in kappa-opiate tolerance in mice.

  1993cited by this paper
• Blockade of morphine-induced analgesia and tolerance in mice by MK-801.

  1993cited by this paper
• Evidence for the role of nitric oxide in κ-opiate tolerance in mice

  1993cited by this paper
• Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex.

  1993cited by this paper
• Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat.

  1993cited by this paper
• Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons.

  1993cited by this paper
• Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.

  1993cited by this paper
• Inhibition of rat cerebellar nitric oxide synthase by 7‐nitro indazole and related substituted indazoles

  1993cited by this paper
• 7‐Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti‐nociceptive activity in the mouse without increasing blood pressure

  1993cited by this paper
• Characterization of the novel nitric oxide synthase inhibitor 7‐nitro indazole and related indazoles: antinociceptive and cardiovascular effects

  1993cited by this paper
• Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea-pigs is not mediated by sigma binding sites.

  1993cited by this paper
• MK-801 inhibits the development of morphine tolerance at spinal sites.

  1993cited by this paper
• Blockade of mu and kappa 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist.

  1993cited by this paper
• Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor.

  1993cited by this paper
• NO news is good news.

  1992cited by this paper
• Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.

  1992cited by this paper
• Glutamate receptor channels: novel properties and new clones.

  1992cited by this paper
• Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy.

  1992cited by this paper
• NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat.

  1992cited by this paper
• Dextromethorphan and parkinsonism.

  1992cited by this paper
• Nitric oxide, a novel neuronal messenger.

  1992cited by this paper
• NG-nitro-L-arginine prevents morphine tolerance.

  1992cited by this paper
• Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice.

  1992cited by this paper
• A controlled trial of buprenorphine treatment for opioid dependence.

  1992cited by this paper
• Cloning and characterization of inducible nitric oxide synthase from mouse macrophages.

  1992cited by this paper
• The NMDA receptor antagonist CPP abolishes neurogenic “wind-up pain” after intrathecal administration in humans.

  1992cited by this paper
• The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat.

  1992cited by this paper
• Molecular cloning and characterization of the rat NMDA receptor

  1991cited by this paper
• Nitric oxide as a neuronal messenger.

  1991cited by this paper
• Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine.

  1991cited by this paper
• NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.

  1991cited by this paper
• Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.

  1991cited by this paper
• Delayed application of MK-801 attenuates development of morphine tolerance in rats.

  1991cited by this paper
• Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input

  1991cited by this paper
• Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs.

  1991cited by this paper
• Nitric oxide synthesis in the CNS endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues.

  1991cited by this paper
• Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo.

  1991cited by this paper
• Sites for antagonism on the N-methyl-D-aspartate receptor channel complex.

  1991cited by this paper
• Glutamate, nitric oxide and cell-cell signalling in the nervous system.

  1991cited by this paper
• Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat.

  1991cited by this paper
• Modulation of the NMDA receptor by polyamines.

  1991cited by this paper
• Economic costs of drug abuse.

  1991cited by this paper
• Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia.

  1991cited by this paper
• 1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models.

  1991cited by this paper
• Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801.

  1991cited by this paper
• NMDA antagonist neurotoxicity: mechanism and prevention.

  1991cited by this paper
• Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase.

  1991cited by this paper
• The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality.

  1991cited by this paper
• The Effectiveness of Methadone Maintenance Treatment

  1991cited by this paper
• The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-D-aspartate receptor.

  1990cited by this paper
• The behavioral pharmacology of NMDA receptor antagonists.

  1990cited by this paper
• N‐Methyl‐D‐Aspartate Recognition Site Ligands Modulate Activity at the Coupled Glycine Recognition Site

  1990cited by this paper
• Molecular cloning and functional expression of glutamate receptor subunit genes.

  1990cited by this paper
• The treatment of heroin addicts with dextromethorphan: a double-blind comparison of dextromethorphan with chlorpromazine.

  1990cited by this paper
• Localization of nitric oxide synthase indicating a neural role for nitric oxide

  1990cited by this paper
• Opioid-mediated facilitation of long-term potentiation at the lateral perforant path-dentate granule cell synapse.

  1990cited by this paper
• The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.

  1990cited by this paper
• Dextromethorphan for treatment Of complex partial seizures

  1990cited by this paper
• Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates

  1990cited by this paper
• Mortality in heroin addiction: impact of methadone treatment

  1990cited by this paper
• Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

  1990cited by this paper
• Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site.

  1990cited by this paper
• Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.

  1990cited by this paper

• Endocannabinoid and nitric oxide interactions in the brain.

  2025cites this paper
• Lipophilic analogues of D-cysteine prevent and reverse physical dependence to fentanyl in male rats

  2024cites this paper
• Glycine Transporter 1 Inhibitors Minimize the Analgesic Tolerance to Morphine

  2024cites this paper
• Nalmefene Hydrochloride: Potential Implications for Treating Alcohol and Opioid Use Disorder

  2024cites this paper
• The cell-permeant antioxidant D-thiol ester D-cysteine ethyl ester overcomes physical dependence to morphine in male Sprague Dawley rats

  2024cites this paper
• Repeated Morphine Exposure Alters Temporoamonic-CA1 Synaptic Plasticity in Male Rat Hippocampus.

  2024cites this paper
• Microglia in neuroimmunopharmacology and drug addiction

  2024cites this paper
• The epigenetic signatures of opioid addiction and physical dependence are prevented by D-cysteine ethyl ester and betaine

  2024cites this paper
• Oral application of magnesium‐L‐threonate enhances analgesia and reduces the dosage of opioids needed in advanced cancer patients—A randomized, double‐blind, placebo‐controlled trial

  2023cites this paper
• L-cysteine ethyl ester prevents and reverses acquired physical dependence on morphine in male Sprague Dawley rats

  2023cites this paper
• S-ketamine promotes postoperative recovery of gastrointestinal function and reduces postoperative pain in gynecological abdominal surgery patients: a randomized controlled trial

  2023cites this paper
• A distinct impact of repeated morphine exposure on synaptic plasticity at Schaffer collateral‐CA1, temporoammonic‐CA1, and perforant pathway‐dentate gyrus synapses along the longitudinal axis of the hippocampus

  2022cites this paper
• Inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse vulnerability in rats

  2022cites this paper
• A new mechanistic approach for the treatment of chronic neuropathic pain with nitrous oxide integrated from a systems biology narrative review

  2021cites this paper
• N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo:Evidence from an NMDA-induced seizure model in rats.

  2021cites this paper
• Comprehensive Pain Management: Opioid-Naïve Versus Opioid-Tolerant Patients

  2021cites this paper
• An investigation into the antidyskinetic and reinforcing effects of UWA-101 in Sprague Dawley rats

  2020cites this paper
• Direct administration of ifenprodil and citalopram into the nucleus accumbens inhibits cue-induced nicotine seeking and associated glutamatergic plasticity

  2020cites this paper
• Nukleus akumbens core bölgesinde L-NAME ve agmatinin morfin yoksunluğuna etkileri

  2020cites this paper
• Molecular Biology of Opioid Analgesia and Its Clinical Considerations.

  2019cites this paper
• Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence

  2019cites this paper
• Sumatriptan effects on morphine‐induced antinociceptive tolerance and physical dependence: The role of nitric oxide

  2018cites this paper
• The effect of hydroalcoholic extract of Urtica dioica on morphine withdrawal signs in male mice

  2018cites this paper
• Evaluation of the Effect of Coriandrum sativum L. Essentisal oil on Naloxone-Induced Jumping in Morphine-Dependent Mice

  2018cites this paper
• Evaluation of the reinforcing and subjective effects of heroin in combination with dextromethorphan and quinidine.

  2017cites this paper
• Antinociceptive effect of co-administered NMDA and histamine H4 receptor antagonists in a rat model of acute pain

  2017cites this paper
• Hippocampal proteomic and metabonomic abnormalities in neurotransmission and oxidative stress pathways in a chronic phencyclidine rat model

  2016cites this paper
• Opioid ToleranceDevelopment : APharmacokinetic / Pharmacodynamic Perspective

  2016cites this paper
• Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model.

  2015cites this paper
• Study of Centrally-Mediated Analgesic Activities of PsidiumGuajava (Guava) Stem Bark in Rats.

  2015cites this paper
• Analgesic management of acute pain in the opioid-tolerant patient

  2015cites this paper
• NMDARs in neurological diseases: a potential therapeutic target

  2015cites this paper
• Management of acute pain in patients on treatment with opioids.

  2015cites this paper
• Involvement of nitric oxide signaling mechanisms underlying opioid tolerance

  2015cites this paper
• Tolerance to cocaine in brain stimulation reward following continuous cocaine infusions.

  2014cites this paper
• Nitroxidergic modulation of behavioural, cardiovascular and immune responses, and brain NADPH diaphorase activity upon morphine tolerance/dependence in rats

  2014cites this paper
• Antinociceptive effect of clavulanic acid and its preventive activity against development of morphine tolerance and dependence in animal models

  2014cites this paper
• Perioperative management of the opioid tolerant patient for orthopedic surgery.

  2014cites this paper
• Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications

  2014cites this paper
• A Double-Blind, Placebo-Controlled Trial of Dextromethorphan Combined With Clonidine in the Treatment of Heroin Withdrawal

  2014cites this paper
• Effect of post-trial L-NAME administration on cocaine sensitization

  2013cites this paper
• The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain.

  2013cites this paper
• Imidazoline receptor antisera‐selected/Nischarin regulates the effect of agmatine on the development of morphine dependence

  2012cites this paper
• Glutamate mechanisms underlying opiate memories.

  2012cites this paper
• Memantine and dizocilpine interactions with antinociceptive or discriminative stimulus effects of morphine in rats after acute or chronic treatment with morphine

  2012cites this paper
• Effects of the Persian Carum copticum fruit extracts on morphine withdrawal syndrome in mice

  2012cites this paper
• Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance.

  2012cites this paper
• Exogenous sodium hydrosulfide can attenuate naloxone-precipitated withdrawal syndromes and affect cAMP signaling pathway in heroin-dependent rat's nucleus accumbens.

  2012cites this paper
• Periaqueductal gray neuroplasticity following chronic morphine varies with age: role of oxidative stress.

  2012cites this paper
• In vivo sodium salicylate causes tolerance to acute morphine exposure and alters the ability of high frequency stimulation to induce long-term potentiation in hippocampus area CA1.

  2011cites this paper
• Opiates and plasticity.

  2011cites this paper
• Effect of nitric oxide synthase inhibitors on benzodiazepine withdrawal in mice and rats

  2011cites this paper
• Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.

  2011cites this paper
• Sensitive and Rapid HPLC Method for Determination of Memantine in Human Plasma Using OPA Derivatization and Fluorescence Detection: Application to Pharmacokinetic Studies

  2010cites this paper
• A Validated Stability-indicating Reverse Phase HPLC Assay Method for the Determination of Memantine Hydrochloride Drug Substance with UV-Detection Using Precolumn Derivatization Technique

  2010cites this paper
• Endogenous modulation of addiction: chronic pain and the NMDA/NOS cascade.

  2010cites this paper
• IMPROVING MAINTENANCE TREATMENT OF HEROIN ADDICTION

  2009cites this paper
• The neurobiology of opiate tolerance, dependence and sensitization: Mechanisms of NMDA receptor-dependent synaptic plasticity

  2009cites this paper
• Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice.

  2009cites this paper
• Theta pulse stimulation: a natural stimulus pattern can trigger long-term depression but fails to reverse long-term potentiation in morphine withdrawn hippocampus area CA1.

  2009cites this paper
• A survey of acute and chronic heroin dependence in ten inbred mouse strains: evidence of genetic correlation with morphine dependence.

  2008cites this paper
• Supraspinally-administered agmatine attenuates the development of oral fentanyl self-administration.

  2008cites this paper
• The glycine site-specific NMDA antagonist (+)-HA966 enhances the effect of morphine and reverses morphine tolerance via a spinal mechanism.

  2008cites this paper
• NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats

  2008influential citation
• The Role of NMDA Receptor Antagonists in Nicotine Tolerance, Sensitization, and Physical Dependence: A Preclinical Review

  2008cites this paper
• [Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].

  2008cites this paper
• Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery?

  2008cites this paper
• Opioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic Perspective

  2008cites this paper
• Novel medications to treat addictive disorders

  2008cites this paper
• A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.

  2008cites this paper
• 7‐Nitroindazole, nitric oxide synthase inhibitor, attenuates physical dependence on butorphanol in rat

  2008cites this paper
• The effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humans.

  2007cites this paper
• Acamprosate in Alcohol Dependence: Implications of a Unique Mechanism of Action

  2007cites this paper
• The beta‐lactam antibiotic, ceftriaxone, attenuates morphine‐evoked hyperthermia in rats

  2007cites this paper
• Memantine produces modest reductions in heroin-induced subjective responses in human research volunteers

  2007cites this paper
• Acute and Neuropathic Pain

  2007cites this paper
• Effect of Tizanidine, Rilmenidine, and Yohimbine on Naloxon-Induced Morphine Withdrawal Syndrome in Mice

  2007cites this paper
• Finasteride, a 5α-reductase inhibitor, potentiates antinociceptive effects of morphine, prevents the development of morphine tolerance and attenuates abstinence behavior in the rat

  2007cites this paper
• Involvement of the α4β2 nicotinic receptor subtype in nicotine-induced attenuation of Δ9-THC cerebellar ataxia : Role of cerebellar nitric oxide

  2007cites this paper
• Involvement of the alpha4beta2 nicotinic receptor subtype in nicotine-induced attenuation of delta9-THC cerebellar ataxia: role of cerebellar nitric oxide.

  2007cites this paper
• Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.

  2007cites this paper
• Management of an 8-month-old infant with opioid tolerance after 3 weeks in the PICU

  2006cites this paper
• Chapter 111 – Molecular Aspects of Drug Actions: From Receptors to Effectors

  2006cites this paper
• Tolerance to morphine analgesia: evidence for stimulus intensity as a key factor and complete reversal by a glycine site-specific NMDA antagonist.

  2006cites this paper
• Effect of L-NAME/L-Arginine Microinjection into Nucleus Accumbens Shell on Morphine Withdrawal Signs in Male Rats

  2006cites this paper
• The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats.

  2006cites this paper
• Interacción del sistema nitridérgico en el mecanismo de acción del piroxicam y parecoxib.

  2006cites this paper
• NMDA receptors are not alone: dynamic regulation of NMDA receptor structure and function by neuregulins and transient cholesterol-rich membrane domains leads to disease-specific nuances of glutamate-signalling.

  2006cites this paper
• CHAPTER 19 – Cancer Pain Management in the Opioid-Tolerant Patient

  2006cites this paper
• A multifaceted molecule, nitric oxide in oral and periodontal diseases.

  2006cites this paper
• An investigation of the acute and chronic effects of ketamine on cognition.

  2006cites this paper
• Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?

  2005cites this paper
• N-methyl-D-aspartate receptors mediate endogenous opioid release in enteric neurons after abdominal surgery.

  2005cites this paper
• Dextromethorphan differentially affects opioid antinociception in rats

  2005cites this paper
• Is antagonism of α3β4 nicotinic receptors a strategy to reduce morphine dependence

  2005cites this paper
• Nicotinamide: a potential anti-addiction weapon.

  2004cites this paper
• Are glycineB sites involved in the development of morphine tolerance?

  2004cites this paper
• Calmodulin inhibitor trifluoperazine attenuates the development and expression of morphine-induced conditioned place preference in rats.

  2004cites this paper
• Comparison of the Effects of Dextromethorphan, Dextrorphan, and Levorphanol on the Hypothalamo-Pituitary-Adrenal Axis

  2004cites this paper
• The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats

  2004cites this paper